Bogart Wealth LLC’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5
Closed -$508 1856
2025
Q4
$508 Sell
5
-6
-55% -$482 ﹤0.01% 1469
2025
Q3
$602 Buy
+11
New +$550 ﹤0.01% 1364
2023
Q1
Sell
-50
Closed -$2.48K 1139
2022
Q4
$2.48K Sell
50
-60
-55% -$2.45K ﹤0.01% 778
2022
Q3
$4K Buy
+110
New +$4.54K ﹤0.01% 716
2022
Q2
Sell
-50
Closed -$3K 908
2022
Q1
$3K Hold
50
﹤0.01% 628
2021
Q4
$4K Hold
50
﹤0.01% 577
2021
Q3
$5K Hold
50
﹤0.01% 534
2021
Q2
$6K Hold
50
﹤0.01% 497
2021
Q1
$7K Hold
50
﹤0.01% 442
2020
Q4
$6K Buy
+50
New +$6.05K ﹤0.01% 367

Other funds holding EXAS

Bogart Wealth LLC's EXAS Position: Q1 2026 in Review

Bogart Wealth LLC sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5 shares — an estimated $508 sold.

Bogart Wealth LLC first reported a position in EXAS in Q4 2020 and held it in 10 quarters. The position peaked at $7K in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bogart Wealth LLC reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bogart Wealth LLC sold 5 Exact Sciences shares in Q1 2026, an estimated $508.
  • Bogart Wealth LLC first reported a position in Exact Sciences in Q4 2020 and held it in 10 quarters.
  • Bogart Wealth LLC's Exact Sciences position peaked at $7K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.